Tech Company Financing Transactions
PhaseBio Pharmaceuticals Funding Round
AstraZeneca, Fletcher Spaght Ventures and Hatteras Venture Partners participated in a $15.6 million venture round for PhaseBio Pharmaceuticals. The funding round was announced on 11/30/2017.
Transaction Overview
AstraZeneca (Michael Gutch)
Fletcher Spaght Ventures (Guy Fish)
Hatteras Venture Partners (Clay Thorp)
Johnson & Johnson Development Corporation
New Enterprise Associates (James Barrett)
Silicon Valley Bank (Scott McCarty)
Company Information
Malvern, PA 19355
USA
Management Team
Browse more venture capital transactions:
Prev: 11/30/2017: Jaanuu venture capital transaction
Next: 11/30/2017: ReversingLabs venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs